Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Nymox provides update on pivotal U.S. phase III trials in BPH

July 18, 2012

Merus Labs acquires rights to drug for overactive bladder

July 12, 2012

Nymox provides update on phase III NX-1207 study

July 11, 2012

Endpoints met in pivotal trial of Vifor phosphate binder

July 9, 2012

FDA approves Astellas drug for overactive bladder

June 29, 2012

Astellas Pharma set to launch Kiklin capsules in Japan

June 25, 2012

Genkyotex reports phase Ia data on GKT-137831

June 25, 2012

Ampio Pharmaceuticals updates on Zertane pre-IND meeting

June 22, 2012

ChemoCentryx compound shows efficacy in diabetic nephropathy model

June 19, 2012

RDX-5791 studied for effects on sodium excretion in healthy volunteers

June 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...